| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SAMD4A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | SUMO3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CDRT4 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | SH3RF2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | SLC25A37 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | FAM96B | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BAIAP3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | MCAT | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | SPRY4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | GPR83 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
